<DOC>
	<DOCNO>NCT02772471</DOCNO>
	<brief_summary>Invasive intracranial pressure ( ICP ) monitoring , use modality parenchymal pressure transducer external ventricular drain ( EVD ) , provide ICP waveform encapsulate valuable diagnostic monitoring clinical information . HS-1000 device , proprietary new non-invasive ICP monitor , expect display ICP waveform safely accurately minimal discomfort patient , compare standard invasive ICP monitoring procedure use participate institution .</brief_summary>
	<brief_title>Development Evaluation ICP Waveform Tracing Capabilities Safety HS-1000 Device</brief_title>
	<detailed_description>A study conduct 100 patient undergo invasive ICP measurement due suspect ICP elevation , regardless etiology . Each enrol patient monitor HS-1000 device data collect throughout entire procedure . Once data collection do , result non-invasive measurement analyze accordingly . The end-point study collect least half hour measurement participant .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Intracranial Hypertension</mesh_term>
	<criteria>Adult men woman subject , age 18 year old screening visit Subjects neuropathology principal investigator considers include study . Survival expectancy great 72 hour Subject legal authorize representative ( per local regulation ) able willing comply requirement protocol Subject legal authorize representative ( per local regulation ) able understand sign write informed consent participate study Local ear infection Known allergy hypersensitivity test material contraindication test material For woman childbearing potential : pregnancy ( positive pregnancy test ) breastfeeding Subjects currently enrol less 30 day postparticipation investigational device drug study ( ) , receive investigational agent ( ) Any condition may jeopardize study participation ( e.g. , abnormal clinical laboratory find ) interpretation study result , may impede ability obtain informed consent ( e.g. , mental condition )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>intracranial pressure</keyword>
	<keyword>noninvasive monitoring</keyword>
</DOC>